524711
VISTAPH
Start SIP
Invest Now
Start SIP in VISTAPH
Performance
- Low
- ₹8
- High
- ₹8
- 52 Week Low
- ₹7
- 52 Week High
- ₹13
- Open Price₹8
- Previous Close₹8
- Volume6,410
- 50 DMA₹8.22
- 100 DMA₹8.76
- 200 DMA₹9.55
Investment Returns
- Over 1 Month -10.38%
- Over 3 Month -22.58%
- Over 6 Month -30.78%
- Over 1 Year -30.2%
Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!
Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -6.9
- PEG Ratio
- 0.1
- Market Cap Cr
- 46
- P/B Ratio
- 1
- Average True Range
- 0.71
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.2
- RSI
- 43.99
- MFI
- 29.26
Vista Pharmaceuticals Financials
Vista Pharmaceuticals Technicals
EMA & SMA
Current Price
₹7.51
-0.05
(-0.66%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹7.84
- 50 Day
- ₹8.22
- 100 Day
- ₹8.76
- 200 Day
- ₹9.55
Resistance and Support
7.71
- R3 8.53
- R2 8.31
- R1 7.93
- S1 7.33
- S2 7.11
- S3 6.73
Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | (Revised) |
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-19 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Notice of the EGM for the approval of raising of funds. 2. Other business matters. |
Vista Pharmaceuticals F&O
About Vista Pharmaceuticals
- NSE Symbol
- VISTAPH
- BSE Symbol
- 524711
- Managing Director
- Mr. Murali Meraga
- ISIN
- INE427C01021
Similar Stocks to Vista Pharmaceuticals
Vista Pharmaceuticals FAQs
Vista Pharmaceuticals share price is ₹7 As on 10 February, 2026 | 07:47
The Market Cap of Vista Pharmaceuticals is ₹46.2 Cr As on 10 February, 2026 | 07:47
The P/E ratio of Vista Pharmaceuticals is -6.9 As on 10 February, 2026 | 07:47
The PB ratio of Vista Pharmaceuticals is 1 As on 10 February, 2026 | 07:47
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.